SFL history

SFL Services was founded by Shayesteh Fürst-Ladani in 2009, focusing on Regulatory Affairs and successfully expanded in 2010 with the creation of departments for Medical Communication and Public Affairs. Notably, this expansion was rewarded by the 2nd prize for the 2010 North West Switzerland Young Entrepreneur competition.

In 2011, the addition of Legal and Regulatory Intelligence departments was accompanied by the relocation of SFL to larger offices. SFL also obtained Swissmedic Establishment License that allows SFL to act as Swiss Agent and submit MAA to Swissmedic on clients' behalf. Furthermore, Shayesteh became Chairperson of EuropaBio’s Combination Product Group.

In 2012, the SFL Public Affairs group conducted and reported a joint study with EuropaBio on the impact of Health Technology Assessments on EU Small and Medium-sized Enterprises. Furthermore, the formerly EU-focused group expanded to include Swiss Public Affairs. Shayesteh was involved in the DIA European advisory council and, overall, SFL published 8 articles on several key regulatory topics. All these efforts and outcomes were acknowledged and supported by the finalist position at the British-Swiss Chamber of Commerce Awards "Most Promising New Entrepreneur" and by the Award "Outstanding Contribution to a Business" received from the Open University MBA Alumni.

In 2013, SFL appointed its Advisory Board to provide strategic advice and recommendations on the long-term development of SFL and on specific client projects. SFL also opened an office in London. The international expansion of SFL was further marked by the presence of an SFL booth at the DIA Annual meeting in Boston, MA. In the same year, SFL received accreditation for its training courses from the Swiss Association of Pharmaceutical Professionals (SwAPP) Commission for Professional Development and the Swiss Society of Pharmaceutical Medicine (SGPM).

In 2014, SFL staff increased to 21 employees and the Board of Senior Advisors was expanded, particularly with Xavier Luria, former Head of Safety and Efficacy at EMA, who joined SFL as senior advisor and Head of SFL UK. This extension of the SFL team allowed the completion of large regulatory and medical communication projects, including a new survey across seven EU countries for EuropaBio.

With its newly created Events department, SFL co-developed the Medtech&Pharma Platform, which held its 1st congress in Zurich in October 2014. Since 2014, SFL acts as secretariat of the Rare Disease Action Forum, a think-tank focusing on rare diseases in Switzerland. 

In 2015, SFL opened an office in Brussels. To mark this expansion, SFL hosted its 1st event in Brussels, entitled 'A common policy vision for pharma and device field?', supported by eminent speakers including a member of the European Parliament. Additionally, several senior advisors were appointed, joining the SFL Advisory Board in providing strategic advices to SFL clients, in support of the SFL team.